Refeeding Syndrome

What is Refeeding syndrome?

Refeeding syndrome is a potentially life-threatening set of metabolic and clinical complications that can occur when nutrition is reintroduced to malnourished patients after a period of undernutrition or starvation. The reintroduction of calories triggers an insulin surge that shifts phosphate, potassium, and magnesium into cells, lowering their serum levels. This syndrome usually develops within the first 5 days of nutritional replenishment. It can occur in any severely malnourished patient, including those with eating disorders, alcohol use disorder, cancer, postoperative states, or prolonged minimal intake.

What causes Refeeding syndrome?

The pathophysiology of this condition is driven by a sudden spike in insulin secretion after feeding. This hormone forces phosphate, potassium, and magnesium into the intracellular compartment, causing rapid serum depletion. Low phosphate levels impair the production of adenosine triphosphate (ATP), which can lead to myocardial dysfunction, respiratory muscle weakness, hemolysis, rhabdomyolysis, and neurologic complications. Thiamine depletion frequently coexists, which can worsen lactic acidosis.

Risk factors include low body mass index, significant recent weight loss, little or no nutritional intake for 5 to 10 days or longer, alcohol use disorder, baseline electrolyte deficiencies, and conditions such as anorexia nervosa.

What are the signs and symptoms of Refeeding syndrome?

The clinical presentation results directly from severe electrolyte derangements. Manifestations include neuromuscular weakness, paresthesias (tingling or prickling sensations), and seizures. Hypophosphatemia (low serum phosphate) impairs diaphragmatic function and may lead to respiratory weakness or frank respiratory failure.

Cardiovascular strain occurs due to sodium retention and expanded extracellular volume. These fluid shifts produce edema (swelling), tachycardia (rapid heart rate), and hypotension. Early manifestations may be nonspecific, but new weakness, edema, arrhythmias, respiratory symptoms, or neurologic changes after feeding should raise concern for refeeding syndrome.

How is Refeeding syndrome diagnosed?

Diagnosis begins by identifying at-risk individuals through intake history and documented weight loss. Essential lab markers for refeeding syndrome consist of serum phosphate, potassium, and magnesium levels. Clinicians should check baseline electrolytes and glucose before refeeding and give thiamine before or with nutritional support.

Fluid balance should be monitored closely, and continuous telemetry should be used in patients with severe malnutrition or a significant risk of arrhythmia. Frequent reassessment of serum phosphorus guides the safe advancement of caloric intake. A documented decrease of 0.5 mg/dL in phosphate levels serves as a critical signal to pause or slow the refeeding process.

How is Refeeding syndrome treated?

Treatment starts with a cautious nutritional restart, typically limiting intake to 10 kcal/kg/day in severe cases. Medical teams should advance calories gradually while monitoring phosphate, potassium, and magnesium closely. These electrolytes should be corrected and repleted during refeeding, and severe baseline deficiencies may warrant delaying calorie advancement until initial correction has begun.

Thiamine supplementation should be given before or with refeeding to reduce the risk of Wernicke encephalopathy, and multivitamin supplementation is commonly recommended during nutritional rehabilitation. Close monitoring of vital signs, weight changes, and fluid balance directs the use of diuretics or sodium adjustments. Complex cases often require a nutrition support specialist to synchronize these therapies and prevent cardiopulmonary decompensation.

What are the most important facts to know about Refeeding syndrome?

• Refeeding syndrome is a potentially life-threatening set of complications that occurs when nutrition is reintroduced to malnourished patients, leading to dangerous intracellular electrolyte shifts.
• The primary pathophysiology involves an insulin-driven intracellular shift of electrolytes (phosphate, potassium, and magnesium), often accompanied by increased thiamine demand.
• Clinical signs include cardiac arrhythmias, respiratory failure, edema, delirium, or seizures.
• Electrolytes should be monitored closely during the early refeeding period, with high-risk patients often requiring at least daily testing.
• Management requires cautious caloric advancement plus thiamine and appropriate electrolyte supplementation.